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Objectives:  Increase  the  percentage  of  etiological  diagnosis  of  epilepsy  (according  to  the  clas-
sification by  the  2010  ILAE)  using  a  systematic  quick  guide  for  pediatric  patients  with  suspected
epilepsy.
Methods:  Ambispective  cohort  study.  Patients  under  16  years  old  with  suspected  epilepsy  were
studied, and  a  systematic  quick  guide  was  applied  to  the  prospective  group,  and  later  the  two
groups were  compared.  It  was  a  convenience  sample,  with  a  study  period  of  one  year  for  both
groups.
Results: The  prospective  group  was  120  patients  and  the  retrospective  group  71  patients.  Com-
paring  the  epileptic  diagnosis  by  etiology  groups,  in the  prospective  group  (only  outpatient
patients),  3.3%  had  epilepsy  of  an  unknown  cause,  55%  had  epilepsy  of  a  genetic  cause,  36.7%
had epilepsy  of a  structural/metabolic  cause,  and  5%  had  conditions  that  are  not  epilepsy  itself.
Meanwhile in  the  retrospective  group,  52.1%  had epilepsy  of  an  unknown  cause,  11.3%  had
epilepsy  of  a  genetic  cause,  and  36.6%  had  epilepsy  of  a  structural/metabolic  cause  (p  <  0.001).
Conclusions:  Compared  to  other  similar  studies,  the  etiological  percentages  of  epilepsy
increased. Using  the  systematic  quick  guide  proposed,  the  percentage  of  etiological  definitions
of epilepsy  was  increased  in pediatric  patients.
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Introduction
Seizure,  according  to  the International  League  Against
Epilepsy  (ILAE),  is  the  transitory  occurrence  of  signs  and/or
symptoms  due  to  abnormal  excessive  synchronous  neuronal
activity  in the brain.1 Epilepsy  is  a  disorder  of the  brain
defined  as the  presence  of  hyper synchronous  neuronal
activity,  which  is  clinically  expressed  by  any  of  the following
circumstances2:
•  At  least  two  unprovoked  or  reflex  seizures  occurring  more
than  24  hours  apart.
•  An  unprovoked  or  reflex  seizure,  and a  probability  of pre-
senting  further  seizures  over  the next 10  years,  similar  to
the  general  recurrence  risk  (at  least 60%)  subsequent  to
the  onset  of  two  unprovoked  seizures.
•  As  an  integral  part  of an epileptic  syndrome.
An  epilepsy  syndrome  is  a group  of  signs and  symptoms
which  define  a unique  epileptic  condition,  made  up of  con-
vulsive  crises  with  specific  characteristics,  onset  age,  gender
predominance,  etiology,  cognitive  or  behavioral  comorbid-
ity,  daily  variation  or  its  link  to  sleep  and  family history.
Some  triggering  factors  are:  sleep  deprivation,  photic  stimu-
lation,  hyperventilation,  etc., which has direct  implications
in  its management,  evolution  and prognosis  within  neurode-
velopment  and  the result  of the epilepsy,  genetic  tests  and
inheritance.3
In Mexico,  the  prevalence  in the Priority  Programs  for
Epilepsy  centers  is  11--15/1000,  thus  this  numbers  suggest
that  in  our country  the number  of  patients  with  epilepsy  is
around  1.5 million.4 In  2010,  the ILAE  redesigned  the  clas-
sification  of  seizures  and  epilepsy  crises;  dividing  them  into
generalized,  focal  and unknown  crisis  (epileptic  spasms).5
Regarding  to electro-clinical  syndromes  and  other  epilep-
sies,  they  were  classified  according  to  the age of  onset  and
specific  etiology  as  follows:  genetic,  structural/metabolic,
of  unknown  causes,  and  in conditions  which are  not actual
epilepsy.5
The  objective  of  this  paper  was  to  increase  the  percent-
age  of  epilepsies  etiologic  diagnoses  in pediatric  patients
(according  to  the classification  by  the 2010  ILAE)  using  a
systematic  quick  guide  in  pediatric  patients  with  suspected
epilepsy.
Materials  and  methods
An  ambi-directional  cohort  study  was  conducted,  with  inter-
ventionism  in the prospective  group  (with  the application  of
the  proposed  systematic  quick  guide).  The  sample  size  was
at  convenience,  all  patients  who  arrived  during  one  year  in
both  groups.
The  first  group  studied  was  the  prospective  group,  a
systematic  quick  guide  was  used  in this group  (see  annex
1). Inclusion  criteria: patients  under  16  years  of age who
attended  the  ‘‘Dr.  José  E.  González’’  University  Hospital
in  Monterrey,  Nuevo  León,  México  (at  its hospital  admission
area  or  outpatient  clinic) for  the first  time  with  suspicion  of
epilepsy,  and  who  have  been  assessed  by  the Pediatric  Neu-
rology  Service  between  June  18,  2014  and  June  17,  2015.
Exclusion  criteria:  Those patients  who  were 16  years  old
or older.  Elimination  criteria: Patients  with  an incomplete
systematic  quick  guide,  patients  with  an incomplete  clini-
cal  file,  patients  who  were  ruled  out  of  having  epilepsy,  and
epileptic  patients  who  did  not  complete  the minimum  stud-
ies  (EEG and/or  imaging  studies)  in  order  to  classify  them
etiologically.
After  finishing  the  prospective  group,  the retrospective
group  began.  We searched  for  the  registries  of every  patient
who  attended  the Pediatric  Neurology  Outpatient  Clinic
for  the first  time.  All  the files  from  those  patients  were
reviewed,  obtaining  epidemiological  data  and  etiological
diagnoses  of  all patients  with  epilepsy.  Inclusion  criteria:
Patients  under  16  years  of age,  with  suspicion  of  epilepsy.
Exclusion  criteria: Patients  who  were 16  years  of  age or
older.  Elimination  criteria: Patients  who  were  ruled  out  of
having  epilepsy  and patients  with  incomplete  clinical  files.
Databases  for  both  groups  were  set  up  using  Microsoft
Excel  2010. Subsequently,  a statistical  analysis  was  per-
formed  using SPSS  version  20,  where  a  descriptive  statistical
analysis  of  the  prospective  and  retrospective  groups  was
completed,  then  the  comparison  between  both  groups  was
conducted  using  Pearson’s  chi  square  test  (for  the varia-
bles:  gender  and  etiological  diagnosis  of  epilepsy)  and  the
Student  T-test  (for  the  age  variable).  A p <  0.05  value  was
determined  as  a  statistically  significant  result.  This  work  was
approved  by  the  Ethics  Committee  of the School  of Medicine
at  the Autonomous  University  of  Nuevo  Leon  on  April  20th,
2015,  with  the  registry  code  NR15-003.
Results
The  proposed  systematic  quick  guide  was  conducted  on
137  patients  with  suspicion  of  epilepsy.  Eight  patients  were
ruled  out  of  having  epilepsy,  and  thus  were eliminated,  and
another  9 patients  with  epilepsy  were  eliminated  as  well
because  they  did not  comply  with  the  minimum  tests  (EEG
and/or  imaging  studies)  in  order  to  classify  them  etiolog-
ically.  The  prospective  group  included  120  patients,  while
the  retrospective  group  included  71  patients.
First,  a description  of  the  prospective  group  was  done
(Tables  1  and 2), and the Denver  II tool  was  used to  eval-
uate  the patients’  psychomotor  capability.  Subsequently,
an  age  comparison  between  prospective  groups  (patients
admitted  plus  outpatients,  and  only  outpatients)  and  the
retrospective  group  was  conducted  (Table 3).  Lastly,  a  com-
parison  of epilepsy  diagnosis  by etiological  groups  was  done
between  prospective  groups  (patients  admitted  plus  outpa-
tients,  and  only  outpatients)  and the retrospective  group
(Table 4).
Discussion
A total  of 120  patients  were  included  in the  prospective
group  and  71  patients  in the retrospective  group.  Aver-
age  age  was  6.3  years  for the first  group  and 7.7  for  the
second  group,  compared  to  a  study  conducted  in Spain
where  the average  age was  5.2 years.6 Gender  distribu-
tion  in the prospective  group  was  66.7%  male  and  33.3%
female,  whereas  for the retrospective  group  the distribu-
tion  was  66.2%  male  and 33.8%  female,  compared  to a
study  conducted  in Turkey  where 59.3%  of  the patients
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Table  1  Description  of  the  prospective  group  (in-hospital
and ambulatory  patients).
Variant  Number  Percentage
Hereditary  or  family  history  of  epilepsy
Negative  88  73.3%
Positive  32  26.7%
Psychomotor  development
Normal  85  70.8%
Abnormal  35  29.2%
Presentation  of seizures
Awake 93  77.5%
Asleep  12  10
Awake  and  asleep  15  12.5%
Seizure  type
Generalized  100 83.3%
Focal  17  14.2%
Unknown  (epileptic  spasms)  3  2.5%
Type of  generalized  seizure
Tonic-clonic  35  35%
Tonic  34  34%
Absence  12  12%
Clonic  8  8%
Atonic  6  6%
Myoclonic  4  4%
Clonic  +  Myoclonic  1  1%
Type of  focal  seizure
Motor  15  88.2%
Autonomic  1  5.9%
Psychic  phenomena 1  5.9%
Sensitive  0  0%
Performance  of electroencephalogram
Performed  117 97.5%
Not performed  3  2.5%
Electroencephalogramresult
Abnormal  101 86.3%
Normal  16  13.7%
Performance  of imaging  study
Performed  96  80%
Not performed  24  20%
Type of  imaging  study  performed
MRI 71  74%
Computed  axial  tomography  25  26%
Result  of  the  imaging  study
Abnormal  65  67.7%
Normal  31  32.3%
Physical  neurological  examination
Abnormal  85  70.8%
Normal  35  29.2%
were  male  and  40.7%  were  female.7 In the  prospective
group,  26.7%  had  family  history  of  epilepsy,  compared  to
the  22.2%  and  22.5%  of studies  conducted  in Germany8
and  Turkey,7 respectively.  In  the  prospective  group,  83%
of  patients  presented  a  generalized  seizure  crisis,  14.2%
Table  2 Prospective  group  (in-hospital  and  ambulatory
patients).
Variant  Average  ±SD
Age  at  first  seizure  (in  years)  4.4  4.5
Duration of  seizures  (in  min)  8.1  19
Duration of  postictal  period  (in  min)  74.6  155.9
SD: Standard deviation.
presented  a focal  and 2.5%  presented  an unknown  (epilep-
tic  spasms),  in  comparison  to  a study  conducted  in Iceland9
where  58%  of  patients  presented  a generalized  seizure  cri-
sis,  40%  presented  a  focal  and 2%  presented  an  unknown;
furthermore,  a study  conducted  in the US10 showed  40%
of  patients  with  a  generalized  seizure  crisis,  57%  with  a
focal  and  3% with  an unknown  seizure  crisis.  This  gap  in
percentages  can  be attributed  to  the difficulty  to  express
clinical  characteristics  of the  crisis  by  people  who  witness
them  (they  might  have  started  focally  and  later  become
generalized).  Regarding  the  prospective  group,  70.8%  of
patients  presented  some  anomaly  in the  neurological  phys-
ical  examination,  while  a  study  in Turkey  reported  only  a
25.8%  of patients  presenting  neurological  anomalies.7 This
could  be due  to  the fact that any  neurological  abnormality,
including  abnormalities  in the  higher  brain  functions,  were
considered  anomalies  in this  study.  If  we  change  the  nomen-
clature  of  the epileptic  etiology  from  the  symptomatic
epilepsy,  idiopathic  epilepsy  and cryptogenic  epilepsy  of
the  old  ILAE  1989  classification,  to  the  structural/metabolic
epilepsy,  genetic  epilepsy  and  epilepsy  with  an unknown
cause,  respectively,  from  the new  classification  from  the
ILAE  2010,  the  prospective  group  (inpatient  and  ambulatory)
had  2.5%  unknown  cause, 31.7%  genetic  cause  (electro-
clinical  syndromes),  61.7%  structural/metabolic  causes,  and
4.2%  which  were  not  epilepsy,  strictly  speaking.  In the  ret-
rospective  group,  we  found that  52.1%  of  the  patients  had
epilepsy  of  an unknown  origin,  11.3%  had epilepsy  of  a
genetic  origin,  36.6%  had  epilepsy  of  a  structural/metabolic
origin,  and  0% had  conditions  which were  not  epilepsy,
strictly  speaking.  We  can  compare  our  results  to  those  of
a  study  in Iceland,9 where  53%  of the patients  had  epilepsy
of an unknown  origin,  14%  had  epilepsy  of  a genetic  ori-
gin,  32%  had epilepsy  of  a structural/metabolic  origin,  and
1% had  conditions  which  were  not  epilepsy,  strictly  speak-
ing.  Another  study  in  Switzerland11 concluded  that  35%  of
the  patients  had epilepsy  of an unknown  origin,  10.3%  had
epilepsy  of  a genetic  origin,  54%  had epilepsy  of  a struc-
tural/metabolic  origin,  and 1% had conditions  which  were
not  epilepsy,  strictly  speaking.
The  positive  aspects  of  this  study include the  following:
it is  a cohort,  ambi-perspective  study  in a third level hospi-
tal,  which is  a reference  center  for  the  northeast  of  Mexico.
It  includes  an important  number  of patients  with  epilepsy  in
both  groups  (prospective  and  retrospective),  and  the gen-
ders  and  ages  within  both  groups  were homogenous  and
therefore  comparable.  Other  points  in favor  of  this study
are:  the inclusion  of  clinical,  demographic,  epidemiolog-
ical  and therapeutic  characteristics,  creating  a database
for  these patients.  With  the systematic  rapid  guide pro-
posed  in this study  for  pediatric  patients  under  suspicion
of epilepsy,  this  study  showed,  with  statistical  importance,
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Table  3  Age  comparison  between  the  prospective  groups  (in-hospital  and  ambulatory  patients,  and only ambulatory  patients)
and the  retrospective  group.
Group  Average  (in  years)  ±SD  p
Age
Prospective  (in-hospital  and ambulatory  patients)  6.3  5
0.076
Retrospective  7.7  5
Prospective (ambulatory  patients)  8.2  4.6
0.509
Retrospective  7.7  5
SD: Standard deviation.
Table  4  Comparison  of  the  epilepsy  diagnosis  by etiological  groups  between  the  prospective  groups  (in-hospital  and  ambulatory
patients, and  only  ambulatory  patients)  and  the  retrospective  group.
Group  Diagnosis  of  epilepsy  by  etiological  group Number  Percentage  p
Prospective  (in-hospital  and
ambulatory  patients)
Epilepsy  of  an  unknown  cause  3  2.5%
<0.001
Epilepsy  of  a  genetic  cause  38  31.7%
Epilepsy  of  a  structural/metabolic  cause  74  61.7%
Conditions  that  are  not  epilepsy,  strictly  speaking  5  4.1%
Retrospective
Epilepsy  of  an  unknown  cause  37  52.1%
Epilepsy  of  a  genetic  cause  8  11.3%
Epilepsy  of  a  structural/metabolic  cause  26  36.6%
Conditions  that  are  not  epilepsy,  strictly  speaking  0  0%
Prospective (ambulatory  patients)
Epilepsy  of  an  unknown  cause  2  3.3%
<0.001
Epilepsy  of  a  genetic  cause  33  55%
Epilepsy  of  a  structural/metabolic  cause  22  36.7%
Conditions  that  are  not  epilepsy,  strictly  speaking 3  5%
Retrospective
Epilepsy  of  an  unknown  cause  37  52.1%
Epilepsy  of  a  genetic  cause  8  11.3%
Epilepsy  of  a  structural/metabolic  cause  26  36.6%
Conditions  that  are  not  epilepsy,  strictly  speaking 0  0%
that  this  guide  decreases  the ‘‘unknown  cause’’  diagnoses
of  epilepsy  and it  increases  the diagnoses  of genetic  and
structural/metabolic  epilepsy  for our  pediatric  patients.
Both  study  groups  were  evaluated  over the  course  of a
year,  and  it  would be  important  to  extend  the  follow-up
time  for  these patients.  This  study  has  aspects  which could
be  improved:  2.5%  of  the  patients  in the  prospective  group
did  not  recieved  an electroencephalogram,  due  to  death  or
surgical  or  medical  complications,  or  they  were  discharged
before  an  electroencephalogram  could  be  performed.  20%
of  the  patients  did  not recieved  any  brain  imaging  stud-
ies,  some  of them  due  to  a lack  of  economic  resources
and  some  due  to  contraindications  from  the sedative  drugs
during  the  study,  due  to which  some  patients  may  have
been  subdiagnosed  with  epilepsy  of  a structural  origin.  The
genetic  studies  were  no performed  on  patients  from  both
groups;  it  will  be  important  for  some patients  to corrobo-
rate  their  epileptic  diagnosis  in  the future,  for  which  they
will  have  to be  cheaper,  as they  currently  cost  around  20,000
MXN,  which  is  quite  inaccessible  for  the  population  at  our
hospital.  This  study  did  not document  the  frequency  of  con-
vulsive  crises  before  and  after  the epilepsy  diagnosis,  and  if
there  was some  electric  or  clinical  improvement  after  having
made  the  etiological  diagnosis  using  the proposed  systematic
quick  guide,  and  treating  them accordingly.  Because  of  this,
we  recommend  a  follow-up  study  to  corroborate  clinical  or
electric  improvement  in these  patients.  Some  patients  in
the  genetic  epilepsy  category  may  also  have  been  ‘‘over-
diagnosed’’  when we  used  the guide to  determine  their
etiology.
Another  negative  aspect  of  this study  is  that  we  were
unable  to  document  all  the variables  in the  retrospective
group  that  we  were  able  to  do with  the  prospective  group.
In  this  study,  we  can  conclude  that  the  rapid  systemic
guide  we  used can  be corroborated  with  statistical  signif-
icance  with  the  increase  in the etiological  definition  of
epilepsy  in pediatric  patients,  both  in-hospital  and  ambu-
latory.  This  guide  can  be used  by  first contact  doctors
or  pediatric  neurologists  to  create  a proper  diagnostic
approach  oriented  toward  all  patients  under  suspicion  of
epilepsy,  to  find an  etiology  diagnosis  in accordance  with  the
2010  ILAE  classification.  This  determination  of  the  specific
etiology,  as  well  as  the electro-clinical  syndromes,  will  allow
us  to  provide  a  complete  management,  oriented  on  and rec-
ommended  by  the international  guides  for each patient,
which  will  help  us to  predict  the  clinical  prognosis  of  our
patients  with  greater  exactitude.
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Appendix A.
Annex 1: Rapid Systematic Guide (1st version) 
 “Dr. José E. González” University Hospital 
Pediatric Neurology Service 
Date: ____________________   Register: ____________ ____________    Age: ______ 
Name: _____________________________________________ ___________________ 
Address and telephone number: 
___________________________________________________ __________________ 
Sex:________        Weight (in kg): ____________           Height (in cm): ___________ 
Head circumference (in cm): _________________         Department: _______________ 
Family history of seizures/epilepsy, psychiatric or neurological abnormalities:  
No __________     Yes (specify) ___________________ ____________________ 
Other family history: _____________________________ _________________ 
# Pregnancy: __________     Prenatal control: _____ _____       Course: _____________ 
Type of birth: __________________________ Motive: _____________ 
Gestational age: ___________________________ Apgar score: ___________ 
Weight at birth: ________________ Height at birth: _____________     Head 
circumference at birth: ________ 
Complications at birth: _________________________________ 
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Previous diseases, surgeries or hospitalizations: No_________                Yes ___________ 
Specify: _______________________________________________________________ 
Psychomotor development (in months or years) 
Cephalic Hold: _________     Sedestation: ___________  Bipedestation: ____________ 
Walking: __________   Jumping: __________Potty training: ____________   
First word: __________ 
Age at first seizure: ________________________________________ 
Date of latest seizure: __________________________________________________ 
Seizure happens when: Awake _____    Asleep _____   Both (awake and asleep) ______ 
Types of seizures 
Generalized (specify if tonic-clonic, absence, myoclonic, tonic, clonic, atonic) 
________________________________________________________________________ 
Epileptic spasms ___________________________________________________________ 
Focal (specify if motor, sensory, autonomic or psychic) 
___________________________________________________________________ 
Discognitive data: No __________ Yes (specify) ______________________________ 
Duration of seizures: _______________________________________________________ 
Gaze deviation: Yes (specify direction) ___________________________ No _________ 
Postictal period: No _____ Yes (specify duration) _____________________________ 
Frequency of seizures (specify number of seizures):
Per day: ____________________________          Per week: _________________________ 
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Per month: _____________________           Per year: _____________________________ 
Conventional or invasive electroencephalogram, polysomnography or EEG video (specify 
date and interpretation): 
_________________________________________________________________________
_________________________________________________________________________ 
Imaging study (structural or functional, specify date and interpretation): 
_________________________________________________________________________
_________________________________________________________________________ 
Paraclinical diagnostic studies (specify if genetic, biopsy or metabolic): 
_________________________________________________________________________ 
Current treatment used (to specify the reason, if a medication was changed or added): 
_________________________________________________________________________
_________________________________________________________________________ 
Specify the anomalies found in the physical, neurological examination: 
_________________________________________________________________________
_________________________________________________________________________ 
Etiological suspicion of epilepsy, according to the ILAE (2010) 
I- Genetic (electroclinical syndrome) by age of onset 
Neonatal period (<44 weeks gestation)1- 
Benign neonatal familial epilepsy _______ a) 
Early myoclonic encephalopathy _______ b) 
Ohtahara syndrome _______ c) 
Lactation ( <1 years) 2- 
Childhood epilepsy with migrant focal seizures _______ a) 
West syndrome _______ b) 
Documento descargado de http://www.elsevier.es el 25-08-2016
70  L.R.  Morales-Mancías  et  al.
Myoclonic epilepsy in infancy _______ c) 
Benign childhood epilepsy _______ d) 
Benign childhood familial epilepsy _______ e) 
Dravet syndrome _______ f) 
Myoclonic encephalopathy in non-progressive disorders _______ g) 
Childhood (1 to 12 years) 3- 
Febrile seizures _______ a) 
Panayiotopoulos syndrome _______ b) 
Myoclonic epilepsy with atonic crises _______ c) 
Benign epilepsy with centrotemporal spikes _______d) 
Autosomal nocturnal frontal lobe epilepsy _______ e) 
Late childhood occipital epilepsy _______ f) 
Epilepsy with myoclonic absences _______ g) 
Lennox-Gastaut syndrome _______ h) 
Epileptic encephalopathy with continuous spiked waves during sleep ______ i) 
Landau-Kleffner syndrome _______ j) 
Childhood absence epilepsy _______ k) 
Adolescent-Adult (>12 years) 4- 
Juvenile epilepsy with absences_______ a) 
Juvenile myoclonic epilepsy _______ b) 
Epilepsy with only tonic-clonic seizures _______c) 
Progressive myoclonic epilepsies _______ d) 
Autosomal dominant epilepsy with auditory symptoms _______ e) 
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Other hereditary temporal lobe epilepsies _______ f) 
Not related to age 5- 
Familiar focal epilepsy with diverse foci  (chil dhood adulthood)_______ a) 
Reflexive epilepsies _______ b) 
II- Structural/Metabolic 
Distinctive constellations 1-
Mesial temporal lobe epilepsy with hippocampal sclerosis _______ a) 
Rasmussen syndrome _______ b) 
Gelastic crisis with hypothalamic hamartoma ____ ___ c) 
Hemiconvulsion-hemiplegia epilepsy _______ d) 
Epilepsies that don’t fall into these diagnostic categories can be distinguished first e) 
by the presence or absence of some known structural or metabolic condition (a suspected 
cause) and also on the basis of the type of the first crisis (focal or generalized 
Attributed epilepsies organized by structural-metabolic causes 2- 
Malformations of cortical development _______ a) 
Neurocutaneous syndromes _______ b) 
Tumor ______ c) 
Infection _______ d) 
Trauma _______ e) 
Angioma 3- 
Perinatal injuries ______ a) 
Apoplexy _______ b) 
III- Unknown and conditions that are not epilepsy, strictly speaking 
Unknown _______ 1- 
Benign neonatal seizures _______ 2- 
Febrile seizures _______ 3- 
Definitive diagnosis of epilepsy (date at which the diagnosis was made):  
________________________________________________________________________ 
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